K M Jordan
University of Southampton
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by K M Jordan.
Annals of the Rheumatic Diseases | 2005
K M Jordan; Holly E. Syddall; Patrick Garnero; Evelyne Gineyts; Elaine M. Dennison; Avan Aihie Sayer; Pierre D. Delmas; C Cooper; N K Arden
Objective: To investigate the association between biochemical markers of bone, cartilage, and synovial turnover with the presence and severity of knee osteoarthritis (OA) in men. Methods: 176 men aged 59–70 years from the MRC Hertfordshire Cohort were studied. Weightbearing anteroposterior and lateral semiflexed radiographs were taken of both knees. A lifestyle questionnaire including basic demographic details and a questionnaire detailing knee pain was completed. This random sample was stratified based on the Kellgren and Lawrence (K&L) score, and the following biochemical markers were analysed: serum osteocalcin, serum C-terminal crosslinked telopeptide of type I collagen (CTX-I), urinary C-terminal crosslinked telopeptide of type II collagen (CTX-II), and urinary glucosyl-galactosyl-pyridinoline (Glc-Gal-Pyd). Results: Age, body mass index (BMI), social class, smoking, and alcohol consumption were similar across K&L grades. Only one subject had a grade 4 K&L score, and was amalgamated with grade 3 subjects. A strong significant association was found between the presence of knee OA and urinary CTX-II and urinary Glc-Gal-Pyd (p = 0.0001 and p = 0.009), which persisted after adjustment for age and BMI. A significant positive association was also found between urinary CTX-II and urinary Glc-Gal-Pyd and the severity of K&L grade, joint space narrowing, and osteophytes scores, which persisted after adjustment for age and BMI. No associations between the presence and severity of knee OA were found for serum CTX-I or serum osteocalcin. Conclusions: Urinary CTX-II and Glc-Gal-Pyd, but not systemic markers of bone turnover, are strongly associated with disease severity and the presence of OA at the tibiofemoral and patellofemoral joints in men.
BMJ | 2004
C Cooper; K M Jordan
Best used for short periods during flare-ups in the disease
Annals of the Rheumatic Diseases | 2003
K M Jordan; N K Arden; Michael Doherty; Bernard Bannwarth; J. W. J. Bijlsma; Paul Dieppe; Klaus-Peter Günther; H J Hauselmann; Gabriel Herrero-Beaumont; P Kaklamanis; Stefan Lohmander; Burkhard F. Leeb; Michel Lequesne; Bernard Mazières; E Martin-Mola; Karel Pavelka; Adrian Pendleton; L Punzi; U Serni; B. Swoboda; G Verbruggen; I Zimmerman-Gorska; Maxime Dougados
Rheumatology | 2003
K M Jordan; S Sawyer; P Coakley; Helen Smith; C Cooper; N K Arden
The Journal of Rheumatology | 2005
K M Jordan; Holly E. Syddall; Elaine M. Dennison; C Cooper; N K Arden
Rheumatology | 2002
K M Jordan; Christopher J. Edwards; N K Arden
Annals of the Rheumatic Diseases | 2003
K M Jordan; N K Arden; Bernard Bannwarth; J. W. J. Bijlsma; Klaus-Peter Günther; Paul Dieppe; H J Hauselmann; Gabriel Herrero-Beaumont; R Kaklamanis; Burkhard F. Leeb; M Lesquesne; Stefan Lohmander; B Maziere; Emilio Martín Mola; Karel Pavelka; L Punzi; U Serni; B. Swoboda; A Verbruggen; I Zimmermann-Gorska; Michael Doherty; Maxime Dougados; Adrian Pendleton; Francoise Cluzeau
BMJ | 2011
Alastair L Hepburn; Tom Rider; K M Jordan
BMJ | 2011
Alastair L Hepburn; Tom Rider; K M Jordan
Rheumatology | 2009
A N Colebatch; K M Jordan; Lyndsey M. Goulston; E M Dennison; C Cooper; N K Arden